fda compound tirzepatide 🚨There's been a lot of confusion lately, so let's clear this up… Compounded GLP-1 medications (like semaglutide and tirzepatide) are not banned entirely — but access is changing. The has ended Did the FDA Ban Compounded

Ni et al., 2024)

Clinical data reveals a mean weight loss of 16.6%

Consequently, clinical communication can shift from binary assertions (effective/ineffective, safe/unsafe) to a framework of probabilities + intervals + acceptance thresholds. For instance, the posterior probability of reaching a clinically meaningful weight-loss threshold can be presented alongside the posterior uncertainty of benefits in hard reproductive endpoints, rather than replacing the decision process with a single P -value

Apocynin also increased the number of surviving DA neurons in MPTP-treated marmosets with 8.5 % (P = 0.059), indicating a tendency towards a neuroprotective efficacy

Research suggests compounds like berberine and certain probiotics may influence metabolic health and pathways associated with GLP-1, though overall evidence is emerging and not equivalent to pharmaceutical GLP-1 agonist trials

Low glutathione levels have also been associated with premature aging